Literature DB >> 17368910

Parental acceptance of Human Papillomavirus vaccines.

Charlotte H Lenselink1, Marloes M J G Gerrits, Willem J G Melchers, Leon F A G Massuger, Dennis van Hamont, Ruud L M Bekkers.   

Abstract

OBJECTIVE: To determine whether parents would accept Human Papillomavirus (HPV) vaccination for their children and which variables may influence their decision, including knowledge about cervical cancer and HPV. STUDY
DESIGN: Three hundred and fifty-six parents of children aged 10-12 years were interviewed regarding the acceptance of an HPV vaccine for their children and their knowledge of HPV and cervical cancer. All data were recorded anonymously. Results were compared using the chi(2)- and the Mann-Whitney test.
RESULTS: HPV vaccination would be accepted by 88% of the parents, preferably when the child is aged 10-12 years. Parents of children who received all the vaccinations of the National Vaccination Programme accepted HPV vaccination significantly more. Less than a third of all parents had heard of HPV, and 14% were aware of the causal relationship of HPV and cervical cancer. Knowledge of HPV and cervical cancer, religion, age, education, and marital status did not show any significant relation with HPV vaccine acceptance.
CONCLUSIONS: A majority of the parents would accept HPV vaccination. HPV vaccine acceptance seems to be dependent on vaccine acceptance in general, even more than on knowledge of HPV and its causal relation with cervical cancer. However, parents requested more information about cervical cancer, HPV, and HPV vaccination, before the HPV vaccine is introduced.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17368910     DOI: 10.1016/j.ejogrb.2007.02.012

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  34 in total

1.  HPV vaccine decision-making and acceptance: does religion play a role?

Authors:  Rachel C Shelton; Anna C Snavely; Maria De Jesus; Megan D Othus; Jennifer D Allen
Journal:  J Relig Health       Date:  2013-12

2.  Influential factors in HPV vaccination uptake among providers in four states.

Authors:  Emily L McCave
Journal:  J Community Health       Date:  2010-12

3.  Human papillomavirus vaccine intentions among men participating in a human papillomavirus natural history study versus a comparison sample.

Authors:  Ellen M Daley; Stephanie L Marhefka; Eric R Buhi; Cheryl A Vamos; Natalie D Hernandez; Anna R Giuliano
Journal:  Sex Transm Dis       Date:  2010-10       Impact factor: 2.830

4.  Perceptions of Human Papillomavirus (HPV) infection and acceptability of HPV vaccine among men attending a sexual health clinic differ according to sexual orientation.

Authors:  Massimo Giuliani; Maria Fenicia Vescio; Maria Gabriella Donà; Alessandra Latini; Mirko Frasca; Manuela Colafigli; Massimo Farinella; Giovanni Rezza; Antonio Cristaudo
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

5.  The Role of the Dental Community in Oropharyngeal Cancer Prevention Through HPV Vaccine Advocacy.

Authors:  Thomas Luke Arnell; Collin York; Alexis Nadeau; Maeve Lauren Donnelly; Laura Till; Pedram Zargari; Wendy Davis; Christine Finley; Thomas Delaney; Jan Carney
Journal:  J Cancer Educ       Date:  2021-04       Impact factor: 2.037

6.  Human papillomavirus vaccine delivery strategies that achieved high coverage in low- and middle-income countries.

Authors:  D Scott LaMontagne; Sandhya Barge; Nga Thi Le; Emmanuel Mugisha; Mary E Penny; Sanjay Gandhi; Amynah Janmohamed; Edward Kumakech; N Rocio Mosqueira; Nghi Quy Nguyen; Proma Paul; Yuxiao Tang; Tran Hung Minh; Bella Patel Uttekar; Aisha O Jumaan
Journal:  Bull World Health Organ       Date:  2011-09-01       Impact factor: 9.408

7.  Ethnic and racial differences in HPV knowledge and vaccine intentions among men receiving HPV test results.

Authors:  Ellen M Daley; Stephanie Marhefka; Eric Buhi; Natalie D Hernandez; Rasheeta Chandler; Cheryl Vamos; Stephanie Kolar; Christopher Wheldon; Mary R Papenfuss; Anna R Giuliano
Journal:  Vaccine       Date:  2011-04-01       Impact factor: 3.641

Review 8.  Quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®): a review of its use in the prevention of premalignant genital lesions, genital cancer and genital warts in women.

Authors:  Paul L McCormack; Elmar A Joura
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

Review 9.  Integrating clinical, community, and policy perspectives on human papillomavirus vaccination.

Authors:  María E Fernández; Jennifer D Allen; Ritesh Mistry; Jessica A Kahn
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

10.  Parental attitudes and information needs in an adolescent HPV vaccination programme.

Authors:  R Stretch; S A Roberts; R McCann; D Baxter; G Chambers; H Kitchener; L Brabin
Journal:  Br J Cancer       Date:  2008-11-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.